Emerson Electric EMR
US equityMarket cap rank #237Specialty Industrial MachineryArtificial IntelligencePhysical AINuclear Power
$162.35 −$0.26 (-0.16%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $162.35 0.00%
Open$164.67
Prev close$162.61
Day range$161.13 – $165.00
Volume2.65M
Market cap$90.56B
P/E (TTM)33.9
Dividend yield1.37%
Earnings
Average move on report day±4.5%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+10.4%
Worst reaction-7.6%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 4 Aug 2026 | After Market | ±4.6% | +2.29% | Within range |
| 2026/Q2 | 5 May 2026 | After Market | ±5.0% | +6.94% | Bigger than priced |
| 2026/Q1 | 3 Feb 2026 | After Market | ±4.9% | +3.43% | Within range |
| 2025/Q4 | 5 Nov 2025 | Pre Market | ±5.0% | -3.84% | Within range |
| 2025/Q3 | 6 Aug 2025 | Pre Market | ±5.4% | -4.72% | Within range |
| 2025/Q2 | 7 May 2025 | Pre Market | ±4.7% | +2.41% | Within range |
| 2025/Q1 | 5 Feb 2025 | Pre Market | ±5.7% | -2.29% | Within range |
| 2024/Q4 | 5 Nov 2024 | Pre Market | ±5.9% | +7.16% | Bigger than priced |
| 2024/Q3 | 7 Aug 2024 | Pre Market | ±6.3% | -7.65% | Bigger than priced |
| 2024/Q2 | 8 May 2024 | Pre Market | ±4.9% | +4.89% | Within range |
| 2024/Q1 | 7 Feb 2024 | Pre Market | ±4.0% | +10.43% | Bigger than priced |
| 2023/Q3 | 2 Aug 2023 | Pre Market | ±3.2% | +3.83% | Bigger than priced |
| 2023/Q2 | 3 May 2023 | Pre Market | ±3.4% | +1.95% | Within range |
| 2023/Q1 | 8 Feb 2023 | Pre Market | ±3.0% | -5.69% | Bigger than priced |
| 2022/Q4 | 2 Nov 2022 | Pre Market | ±2.7% | -1.05% | Within range |
| 2022/Q3 | 9 Aug 2022 | Pre Market | ±3.6% | -3.82% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Jun 2026
Revenue$4.87B+7.0% YoY
Operating profit$1.11B+22.0% YoY
Net profit$718.00M+22.5% YoY
Diluted EPS$1.28+23.1% YoY
Free cash flow$1.32B+35.3% YoY
Operating cash flow$1.42B
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin53.2%
Operating margin20.7%
Net margin13.8%
Return on equity12.8%
Return on assets6.1%
Return on invested capital8.3%
Current ratio0.90
Liabilities / assets51.7%
Cash & investments$2.18B
Total debt$13.11B
Net cash (debt)-$10.93B
Free cash flow / sales18.6%
No comments yet — be the first to weigh in on EMR.